1. Home
  2. PCB vs SGHT Comparison

PCB vs SGHT Comparison

Compare PCB & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PCB Bancorp

PCB

PCB Bancorp

HOLD

Current Price

$24.31

Market Cap

344.5M

Sector

Finance

ML Signal

HOLD

Logo Sight Sciences Inc.

SGHT

Sight Sciences Inc.

HOLD

Current Price

$4.36

Market Cap

187.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCB
SGHT
Founded
2003
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
344.5M
187.4M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
PCB
SGHT
Price
$24.31
$4.36
Analyst Decision
Hold
Buy
Analyst Count
2
7
Target Price
$24.50
$9.08
AVG Volume (30 Days)
23.1K
233.4K
Earning Date
04-24-2026
05-07-2026
Dividend Yield
3.63%
N/A
EPS Growth
48.28
28.16
EPS
2.58
N/A
Revenue
$2,899,000.00
$77,363,000.00
Revenue This Year
$13.73
$11.67
Revenue Next Year
$9.07
$10.39
P/E Ratio
$9.39
N/A
Revenue Growth
4.51
N/A
52 Week Low
$18.54
$2.74
52 Week High
$24.99
$9.24

Technical Indicators

Market Signals
Indicator
PCB
SGHT
Relative Strength Index (RSI) 68.57 59.92
Support Level $21.12 $3.30
Resistance Level N/A $5.32
Average True Range (ATR) 0.56 0.21
MACD 0.10 0.13
Stochastic Oscillator 73.40 98.47

Price Performance

Historical Comparison
PCB
SGHT

About PCB PCB Bancorp

PCB Bancorp is a bank holding company, which engages in the provision of consumer and commercial banking services. It provides Personal, Business, and Loan services, which provide banking, lending, and digital, tools, home loans, and others. Also, it offers a broad range of loans, deposits, and other products and services predominantly to small and middle-market businesses and individuals. The company provided it's services in Los Angeles and Orange Counties, California; Bellevue, Washington; and Atlanta, Georgia.

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.

Share on Social Networks: